Calidi Biotherapeutics (CLDI) Q4 2024 Earnings

Nov 12Confirmed
Q2 2024
Q3 2024
Q4 2024
-2.75
-2.05
-1.35
-0.65

Details

Expected EPS
-0.8555
Actual EPS
-0.65
Surprise EPS
0.21
Surprise Percent
+24.02%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDI⁩) has reported earnings of ⁦-0.65⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts